Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kempisty, B. Bialas-Chromiec, D. Borkowska, J. Kus (Warsaw, Poland). What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays. Eur Respir J 2013; 42: Suppl. 57, 3816

Member's Comments

No comment yet.

Related content which might interest you: Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis? Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 False-negative interferon gamma release assay results in active tuberculosis: a TBNET study Source: Eur Respir J 2015; 45: 279-283 Year: 2015 Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Positivity of quantiferon-TB tests in sarcoidosis patients Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Comparison of tuberculin skin test and in-vitro interferon gamma release tests in diagnosis of tuberculosis in children with household tuberculosis contact Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014 Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018 Time interval to conversion of interferon-? release assay after exposure to tuberculosis Source: Eur Respir J 2011; 37: 1447-1452 Year: 2011 CD8-response associates with active tuberculosis and TB2-tube response in the QuantiFERON-TB-Plus kit Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Diagnosis of latent tuberculosis infection in children with the useof different immunological methods Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy Source: Eur Respir J 2014; 44: 1369-1372 Year: 2014 Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Source: International Congress 2015 – Screening strategies in TB Year: 2015 Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010